Pfizer Inc
NYSE: PFE
$25.77
-$0.40 (-1.5%)
Closing Price on November 26, 2024
PFE Articles
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019 rather than looking back at how choppy 2018 has been.
Published:
Last Updated:
24/7 Wall St. screened the Merrill Lynch research database for stocks rated Buy that pay a dividend and have the firm's best volatility risk rating. These five that look like solid picks for 2019 and...
Published:
Last Updated:
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
Published:
Last Updated:
Caterpillar, UnitedHealth, Microsoft, and Pfizer lifted the down to 500-point gain Wednesday.
Published:
Last Updated:
Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination regimens in multiple cancer settings.
Published:
Last Updated:
Apple, Intel, Pfizer, and Merck were the worst performing Dow stocks on Friday.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero Energy and Zynga.
Published:
Last Updated:
Pfizer reported mixed quarterly results before the markets opened on Tuesday and shares retreated in the premarket.
Published:
Last Updated:
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of the Dow companies scheduled to report their quarterly results this week. Here, we have included the consensus earnings estimates from Thomson Reuters, as...
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices for worried investors to consider...
Published:
Last Updated:
Pfizer, in collaboration with Bain Capital, announced the creation of Cerevel Therapeutics, a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central...
Published:
Last Updated: